AAN Aaron's | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.02 -0.4% | $8.00 ➝ $10.10 | Hold ➝ Hold | |
AAN Aaron's | Target Raised by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.02 -0.4% | $8.00 ➝ $10.00 | Hold ➝ Hold | |
AAPL Apple | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $214.29 -1.1% | $225.00 ➝ $245.00 | Overweight ➝ Overweight | |
ABBV AbbVie | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $171.35 +1.0% | $185.00 ➝ $190.00 | Overweight ➝ Overweight | |
ACLX Arcellx | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.81 +0.1% | $87.00 ➝ $87.00 | Buy ➝ Buy | |
ACN Accenture | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $285.34 -0.1% | $398.00 ➝ $350.00 | Buy ➝ Buy | |
|
ADSK Autodesk | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $244.12 +1.5% | $260.00 ➝ $260.00 | Outperform ➝ Outperform | |
ADSK Autodesk | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $244.12 +1.5% | $275.00 ➝ $275.00 | Outperform ➝ Outperform | |
ADUS Addus HomeCare | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $119.30 +1.4% | $119.00 ➝ $128.00 | Buy ➝ Buy | |
ALV Autoliv | Initiated by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $108.80 -2.9% | | Neutral | |
AMRN Amarin | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.73 -3.9% | | Overweight | |
AMTB Amerant Bancorp | Initiated by | Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.19 -1.9% | $25.00 | Buy | |
AON AON | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $297.90 -0.7% | $315.00 ➝ $315.00 | Sector Perform ➝ Sector Perform | |
AVTE Aerovate Therapeutics | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.41 -14.5% | $35.00 ➝ $2.00 | Overweight ➝ Equal Weight | |
AVTE Aerovate Therapeutics | Downgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.41 -14.5% | | Buy ➝ Hold | |
AVTE Aerovate Therapeutics | Downgraded by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.41 -14.5% | $27.00 ➝ $2.00 | Outperform ➝ Inline | |
AYI Acuity Brands | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $250.04 -3.5% | $286.00 ➝ $280.00 | Neutral ➝ Neutral | |
AZEK AZEK | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.76 +0.2% | $57.00 ➝ $57.00 | Buy ➝ Buy | |
BHVN Biohaven | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.77 -0.7% | $59.00 ➝ $59.00 | Outperform ➝ Outperform | |
BILI Bilibili | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.18 +3.0% | $21.00 | Neutral ➝ Overweight | |
BSX Boston Scientific | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.34 +0.2% | $82.00 ➝ $82.00 | Buy ➝ Buy | |
BXMT Blackstone Mortgage Trust | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.93
| $18.00 ➝ $18.00 | Market Perform ➝ Market Perform | |
BYON Beyond | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.77 +1.7% | $19.00 ➝ $15.50 | Neutral ➝ Neutral | |
CATX Perspective Therapeutics | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.93 +15.4% | | Outperform ➝ Outperform | |
CATX Perspective Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.93 +15.4% | | Overweight | |
CDLX Cardlytics | Initiated by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.21 -0.5% | $14.00 | Outperform | |
CELH Celsius | Target Lowered by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.28 +8.3% | $110.00 ➝ $90.00 | Buy ➝ Buy | |
CGNT Cognyte Software | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.60 -5.1% | | Hold | |
CHGG Chegg | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.70 +3.4% | | Hold | |
CLDX Celldex Therapeutics | Initiated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.66 -0.7% | $58.00 | Buy | |
CLDX Celldex Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.66 -0.7% | $67.00 ➝ $67.00 | Overweight ➝ Overweight | |
CLNN Clene | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.38 +2.7% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
CLSK CleanSpark | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.48 +1.2% | $27.00 ➝ $27.00 | Buy ➝ Buy | |
CMG Chipotle Mexican Grill | Target Raised by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3,427.82 +1.9% | $3,668.00 ➝ $3,888.00 | Buy ➝ Buy | |
COIN Coinbase Global | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $235.95 -3.7% | $315.00 ➝ $315.00 | Buy ➝ Buy | |
CPA Copa | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.61 -0.8% | $160.00 ➝ $145.00 | Buy | |
CRH CRH | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.85 -1.1% | $95.00 | Overweight | |
CSGP CoStar Group | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.73 -0.6% | $110.00 ➝ $110.00 | Market Outperform ➝ Market Outperform | |
CTVA Corteva | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.91 -0.2% | $61.00 ➝ $60.00 | Buy ➝ Buy | |
DAY Dayforce | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.14 -1.8% | $72.00 ➝ $66.00 | Buy ➝ Buy | |
[Urgent] Protect your money before November (Ad) Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis.
In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of …
Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed.![](gif/triggeredcampaignpixel49d3.gif) Click here to watch now. |
DBRG DigitalBridge Group | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.31 -1.5% | $21.00 ➝ $17.00 | Buy | |
DBRG DigitalBridge Group | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.31 -1.5% | $18.50 ➝ $17.75 | Outperform ➝ Outperform | |
DT Dynatrace | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.26 -4.7% | | Hold | |
EDIT Editas Medicine | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.04 -0.6% | $12.00 ➝ $12.00 | Market Perform ➝ Market Perform | |
ELF e.l.f. Beauty | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $213.67 +9.3% | $214.00 ➝ $250.00 | Buy | |
ELF e.l.f. Beauty | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $213.67 +9.3% | $214.00 ➝ $250.00 | Buy ➝ Buy | |
ELUT Elutia | Target Raised by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.27 +2.8% | $5.00 ➝ $11.00 | Overweight ➝ Overweight | |
EQH Equitable | Downgraded by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.03 0.0% | $40.00 ➝ $43.00 | Buy ➝ Neutral | |
ET Energy Transfer | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.50 +1.1% | $19.00 ➝ $20.00 | Buy ➝ Buy | |
FC Franklin Covey | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.12 -0.8% | $45.00 ➝ $45.00 | Outperform ➝ Outperform | |
FSLR First Solar | Downgraded by | Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $262.37 +0.4% | | Buy ➝ Neutral | |
GLW Corning | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Roberts Subscribe to MarketBeat All Access for the recommendation accuracy rating | $40.21 +3.8% | $36.00 ➝ $42.00 | Neutral ➝ Neutral | |
HLLY Holley | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.36 +3.1% | $12.00 ➝ $12.00 | Buy ➝ Buy | |
HMN Horace Mann Educators | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.35 +0.9% | | Market Perform | |
HMST HomeStreet | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.50 +3.4% | $13.50 ➝ $13.50 | Market Perform ➝ Market Perform | |
HSY Hershey | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $182.72 -0.2% | $210.00 ➝ $204.00 | Equal Weight ➝ Equal Weight | |
IMVT Immunovant | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $26.19 -2.3% | | Overweight | |
INCY Incyte | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.44 -2.0% | | Neutral | |
INVA Innoviva | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.22 +0.4% | | Overweight | |
ITCI Intra-Cellular Therapies | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.48 +9.6% | $90.00 ➝ $94.00 | Buy ➝ Buy | |
JNPR Juniper Networks | Upgraded by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.56 +0.2% | $40.00 | Hold ➝ Buy | |
JSPR Jasper Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.19 -4.6% | | Overweight | |
KALV KalVista Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.37 -3.8% | $35.00 ➝ $35.00 | Buy ➝ Buy | |
KMB Kimberly-Clark | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.67 +0.9% | $165.00 ➝ $165.00 | Outperform ➝ Outperform | |
KMX CarMax | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.49 -0.3% | $75.00 ➝ $72.00 | Neutral ➝ Neutral | |
KMX CarMax | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.49 -0.3% | $90.00 ➝ $90.00 | Outperform ➝ Outperform | |
KMX CarMax | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.49 -0.3% | $72.00 ➝ $66.00 | Hold ➝ Hold | |
KNF Knife River | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.45 +1.4% | $85.00 | Overweight | |
KOPN Kopin | Initiated by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.71 +1.4% | $2.50 | Buy | |
KR Kroger | Upgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.98 +1.8% | $58.00 ➝ $60.00 | Market Perform ➝ Outperform | |
KROS Keros Therapeutics | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.65 +0.2% | $100.00 ➝ $100.00 | Buy ➝ Buy | |
KROS Keros Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.65 +0.2% | $100.00 ➝ $100.00 | Buy ➝ Buy | |
KURA Kura Oncology | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.77 -4.4% | $32.00 ➝ $32.00 | Market Outperform ➝ Market Outperform | |
LEN Lennar | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating | $148.76 -5.0% | $144.00 ➝ $144.00 | Underperform ➝ Underperform | |
LEN Lennar | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $148.76 -5.0% | $183.00 ➝ $183.00 | Outperform ➝ Outperform | |
LEVI Levi Strauss & Co. | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.53 +0.2% | $23.00 ➝ $26.00 | Buy ➝ Buy | |
MIRM Mirum Pharmaceuticals | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.25 -11.4% | $38.00 ➝ $64.00 | Buy ➝ Buy | |
MIRM Mirum Pharmaceuticals | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.25 -11.4% | $31.00 ➝ $39.00 | Overweight ➝ Overweight | |
MIRM Mirum Pharmaceuticals | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.25 -11.4% | $53.00 ➝ $57.00 | Overweight ➝ Overweight | |
MIRM Mirum Pharmaceuticals | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.25 -11.4% | $66.00 ➝ $68.00 | Market Outperform ➝ Market Outperform | |
MRK Merck & Co., Inc. | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $127.99 +0.4% | $155.00 ➝ $155.00 | Overweight ➝ Overweight | |
MRNS Marinus Pharmaceuticals | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.40 -3.5% | $10.00 ➝ $10.00 | Buy ➝ Buy | |
MRNS Marinus Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.40 -3.5% | $11.00 ➝ $11.00 | Buy ➝ Buy | |
MU Micron Technology | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $153.45 +3.8% | $130.00 ➝ $170.00 | Outperform ➝ Outperform | |
MU Micron Technology | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $153.45 +3.8% | $140.00 ➝ $165.00 | Buy ➝ Buy | |
NFLX Netflix | Target Raised by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $685.67 +1.5% | $700.00 ➝ $750.00 | Buy ➝ Buy | |
NI NiSource | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.07 +0.3% | $31.00 ➝ $31.00 | Outperform ➝ Outperform | |
NOC Northrop Grumman | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $425.87 -0.9% | $530.00 ➝ $500.00 | Hold ➝ Hold | |
NOC Northrop Grumman | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $425.87 -0.9% | $483.00 ➝ $518.00 | | |
NOW ServiceNow | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $730.38 +0.7% | $900.00 ➝ $900.00 | Buy ➝ Buy | |
[Urgent] Protect your money before November (Ad) Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis.
In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of …
Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed.![](gif/triggeredcampaignpixel49d3.gif) Click here to watch now. |
NRIX Nurix Therapeutics | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.44 +20.6% | $19.00 ➝ $26.00 | Buy ➝ Buy | |
NTLA Intellia Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.80 -1.5% | $65.00 ➝ $65.00 | Overweight ➝ Overweight | |
NVDA NVIDIA | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.58 +3.5% | $125.00 ➝ $155.00 | Overweight ➝ Overweight | |
NVDA NVIDIA | Target Raised by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.58 +3.5% | $140.00 ➝ $200.00 | Buy ➝ Buy | |
NVDA NVIDIA | Target Raised by | Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.58 +3.5% | $98.50 ➝ $170.00 | Buy ➝ Buy | |
OGE OGE Energy | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.11 -0.1% | $34.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
OMGA Omega Therapeutics | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.22 +19.4% | $12.00 | Outperform | |
ONON ON | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Civello Subscribe to MarketBeat All Access for the recommendation accuracy rating | $42.24 +1.5% | $46.00 ➝ $46.00 | Buy ➝ Buy | |
ORCL Oracle | Target Raised by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $144.64 +2.4% | $145.00 ➝ $159.00 | Buy ➝ Buy | |
ORRF Orrstown Financial Services | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.33 -0.3% | $32.00 ➝ $32.00 | Outperform ➝ Outperform | |
OVID Ovid Therapeutics | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.79
| $11.00 ➝ $5.00 | Buy ➝ Buy | |
OVID Ovid Therapeutics | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.79
| $9.00 ➝ $3.00 | Buy ➝ Buy | |
OVID Ovid Therapeutics | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.79
| $3.50 ➝ $1.20 | Neutral ➝ Neutral | |
OVID Ovid Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.79
| $9.00 ➝ $3.00 | Buy ➝ Buy | |
OVID Ovid Therapeutics | Downgraded by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.79
| | Outperform ➝ Market Perform | |
PAYC Paycom Software | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.46 -1.0% | $193.00 ➝ $162.00 | Neutral ➝ Neutral | |
PCTY Paylocity | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.87 -3.0% | $225.00 ➝ $195.00 | Outperform ➝ Outperform | |
PCTY Paylocity | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.87 -3.0% | $178.00 ➝ $155.00 | Neutral ➝ Neutral | |
POOL Pool | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $337.89 -1.5% | $415.00 ➝ $370.00 | Hold ➝ Hold | |
PPC Pilgrim's Pride | Initiated by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.53 +2.3% | $41.00 | Buy | |
PRAX Praxis Precision Medicines | Initiated by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.69 +3.1% | $155.00 | Buy | |
PRMW Primo Water | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.17 -2.7% | $24.00 ➝ $26.00 | Overweight ➝ Overweight | |
PRMW Primo Water | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.17 -2.7% | $30.00 ➝ $30.00 | Outperform ➝ Outperform | |
PRMW Primo Water | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.17 -2.7% | $30.00 ➝ $32.00 | Buy | |
PRMW Primo Water | Target Raised by | CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.17 -2.7% | $24.00 ➝ $26.00 | Outperformer ➝ Outperformer | |
PYCR Paycor HCM | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.15 -3.0% | $17.00 ➝ $14.00 | Neutral ➝ Neutral | |
PYPD PolyPid | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.11 -1.7% | $14.00 ➝ $14.00 | Buy ➝ Buy | |
QGEN Qiagen | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.75 +0.0% | $52.00 ➝ $54.00 | Overweight ➝ Overweight | |
QNST QuinStreet | Upgraded by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.21 +4.0% | $22.00 | Hold ➝ Buy | |
QTWO Q2 | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.86 -0.2% | $65.00 ➝ $68.00 | Buy ➝ Buy | |
RBA RB Global | Initiated by | CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.03 -0.5% | $95.00 | Sector Outperform | |
RDDT Reddit | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 60.21 -0.2% | $63.00 ➝ $75.00 | Buy ➝ Buy | |
RGEN Repligen | Initiated by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $123.00 -1.1% | | Neutral | |
RKLB Rocket Lab USA | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.91 +13.1% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
ROIV Roivant Sciences | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.84 +1.1% | | Overweight | |
SILK Silk Road Medical | Reiterated by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.88 +24.0% | $28.00 ➝ $27.50 | Buy ➝ Hold | |
SRAD Sportradar Group | Initiated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.64 -2.7% | $12.00 | Neutral | |
STLD Steel Dynamics | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.00 -1.2% | $140.00 ➝ $135.00 | Market Perform ➝ Market Perform | |
STM STMicroelectronics | Upgraded by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.07 -0.1% | $35.50 ➝ $45.80 | Sell ➝ Neutral | |
STNG Scorpio Tankers | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.74 +3.0% | $82.00 ➝ $85.00 | Neutral ➝ Neutral | |
SUN Sunoco | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.51 -0.2% | $65.00 | Neutral ➝ Buy | |
T AT&T | Reiterated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.07 +2.3% | $24.00 ➝ $24.00 | Buy ➝ Buy | |
TER Teradyne | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $151.75 +4.8% | $130.00 ➝ $170.00 | Buy ➝ Buy | |
TFIN Triumph Financial | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.60 +0.4% | $68.00 ➝ $75.00 | Market Perform ➝ Market Perform | |
TPR Tapestry | Reiterated by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.01 -2.2% | $52.00 ➝ $52.00 | Buy ➝ Buy | |
TPVG TriplePoint Venture Growth BDC | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.82 +0.8% | $9.00 ➝ $9.00 | Underperform ➝ Underperform | |
TSHA Taysha Gene Therapies | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.97 -26.3% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
URBN Urban Outfitters | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.11 +1.4% | $50.00 ➝ $52.00 | Overweight ➝ Overweight | |
VSAT Viasat | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.20 -5.8% | $28.00 ➝ $26.00 | Equal Weight ➝ Equal Weight | |
VZLA Vizsla Silver | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.74 +5.5% | $3.25 ➝ $3.50 | Buy ➝ Buy | |
Historic NVIDIA partnership could send this tiny AI stock soaring... (Ad) After striking partnerships with trillion-dollar chipmaker NVIDIA...
ARM surged over 60% in a week... Who's next?![](gif/triggeredcampaignpixel6e98.gif) Click here to discover the name and ticker symbol >>> |
WDFC WD-40 | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.47 -0.1% | $313.00 ➝ $313.00 | Buy ➝ Buy | |
WING Wingstop | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $428.85 +2.7% | $420.00 ➝ $460.00 | Buy ➝ Buy | |
WMB Williams Companies | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.83 +1.4% | $40.00 ➝ $42.00 | Hold ➝ Hold | |
WOLF Wolfspeed | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.01 -4.0% | $27.00 ➝ $28.00 | Neutral ➝ Neutral | |
XENE Xenon Pharmaceuticals | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.25 -1.0% | $55.00 ➝ $55.00 | Outperform ➝ Outperform | |
XPOF Xponential Fitness | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.05 -0.5% | $18.00 ➝ $20.00 | Buy ➝ Buy | |
ZG Zillow Group | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.55 +4.4% | $52.00 ➝ $52.00 | Buy ➝ Buy | |
ZNTL Zentalis Pharmaceuticals | Downgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $15.00 ➝ $4.00 | Neutral ➝ Underperform | |
ZNTL Zentalis Pharmaceuticals | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $29.00 ➝ $9.00 | Overweight ➝ Equal Weight | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $50.00 ➝ $25.00 | Outperform ➝ Outperform | |
ZNTL Zentalis Pharmaceuticals | Reiterated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $38.00 ➝ $8.00 | Overweight ➝ Equal Weight | |
ZNTL Zentalis Pharmaceuticals | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $42.00 ➝ $6.00 | Buy ➝ Hold | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $32.00 ➝ $10.00 | Buy ➝ Buy | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.14 -50.7% | $40.00 ➝ $20.00 | Buy ➝ Buy | |
ZUO Zuora | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.36 -1.5% | $15.00 ➝ $15.00 | Buy ➝ Buy | |